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Abstract
Recent evidence suggests that the predominant astrocyte
glutamate transporter, GLT-1/ Excitatory Amino Acid Trans-
porter 2 (EAAT2) is associated with mitochondria. We used
primary cultures of mouse astrocytes to assess co-localization
of GLT-1 with mitochondria, and tested whether the interaction
was dependent on neurons, actin polymerization or the kinesin
adaptor, TRAK2. Mouse primary astrocytes were transfected
with constructs expressing V5-tagged GLT-1, pDsRed1-Mito
with and without dominant negative TRAK2. Astrocytes were
visualized using confocal microscopy and co-localization was
quantiﬁed using Volocity software. Image analysis of confocal
z-stacks revealed no co-localization between mitochondria
and GLT-1 in pure astrocyte cultures. Co-culture of astrocytes
with primary mouse cortical neurons revealed more mitochon-
dria in processes and a positive correlation between mito-
chondria and GLT-1. This co-localization was not further
enhanced after neuronal depolarization induced by 1 h treat-
ment with 15 mM K+. In pure astrocytes, a rho kinase inhibitor,
Y27632 caused the distribution of mitochondria to astrocyte
processes without enhancing GLT-1/mitochondrial co-locali-
zation, however, in co-cultures, Y27632 abolished mitochon-
drial:GLT-1 co-localization. Disrupting potential mitochondrial:
kinesin interactions using dominant negative TRAK2 did not
alter GLT-1 distribution or GLT-1: mitochondrial co-localiza-
tion. We conclude that the association between GLT-1 and
mitochondria is modest, is driven by synaptic activity and
dependent on polymerized actin ﬁlaments.
Keywords: co-culture, EAAT2, Glial cell, glutamate
transporter, rho kinase, TRAK2.
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The glutamate transporter GLT-1 [known as Excitatory
Amino Acid Transporter 2 in humans] is an abundant
astrocyte plasma membrane protein, with a critical role in
maintaining L-glutamate homeostasis in the central nervous
system, accounting for at least 95% of all glutamate uptake in
the CNS (Danbolt 2001; Jiang and Amara 2011; Vandenberg
and Ryan 2013). Astrocyte glutamate transporters limit
glutamate receptor activation (Huang and Bergles 2004) and
control glutamate synaptic transmission, particularly under
conditions of high-frequency stimulation of neurons (Beart
and O’Shea 2007; Beurrier et al. 2009). Activity of astrocyte
glutamate transporters controls the glutamate:glutamine cycle
which is required for neurons to maintain adequate levels of
glutamate for transmission (Uwechue et al. 2012). Sodium
ions which enter astrocytes during glutamate uptake are
actively extruded, at the expense of ATP synthesized in
mitochondria. A large portion of the brain’s ATP turnover is
required to remove glutamate from the synaptic cleft (Sibson
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et al. 1998; Anderson and Swanson 2000). Recent evidence
suggests that glutamate transporters, localized in the plasma
membrane, exist in protein complexes to facilitate this
function, namely a direct protein: protein interaction with
sodium-potassium ATPase (Rose et al. 2009) and interaction
through undetermined partners with mitochondrial proteins
(Genda et al. 2011). Therefore, an emerging theory is that
GLT-1 is part of an activity-dependent macromolecular
complex in astrocytes which efﬁciently couples energy
provision to demand to maintain effective neurotransmission
(Genda et al. 2011; Jackson et al. 2014).
This theory predicts that GLT1: mitochondrial co-locali-
zation at the plasma membrane of astrocytes should become
elevated under conditions where demand is increased.
Indeed, GLT-1 expression in astrocytes as determined by
functional assays and protein expression, is dependent on
neurons, or factors secreted from neurons (Swanson et al.
1997; Perego et al. 2000; Poitry-Yamate et al. 2002; Bene-
diktsson et al. 2012), with deafferentation or loss of neuronal
activity leading to loss in glutamate transporter levels
(Ginsberg et al. 1995; Ouyang et al. 2007). Recent evidence
shows that GLT-1 distribution within astrocytes is highly
dynamic, with GLT-1 localization in astrocyte processes
(ﬁlopodia) increasing following activation of neurons (Bene-
diktsson et al. 2012).
Mitochondria in astrocytes have been reported to be highly
motile (Mason et al. 1988), with their activity-dependent
mobility dependent on both interactions with microtubules
and actin ﬁlaments (Kremneva et al. 2013). GLT-1:mito-
chondrial co-localization has been suggested to predominate
in the ﬁne processes (ﬁlopodia) of astrocytes (Genda et al.
2011). However, many ﬁlopodia have a small diameter
which would be expected to exclude mitochondria (Hertz
et al. 2007; Lavialle et al. 2011) and the protein machinery
which controls mitochondrial dynamics in astrocyte ﬁlopodia
remains unknown. The interaction may be dependent on
actin, as rho kinase inhibition which causes remodelling of
actin ﬁlaments, causes astrocyte stellation and increased cell
surface Excitatory Amino Acid Transporter 2 (Lau et al.
2011). In neurons a family of kinesin adaptor proteins
(TRAKs) have been speciﬁcally implicated in mitochondrial
trafﬁcking into ﬁne dendritic processes, through their asso-
ciation with the transmembrane mitochondrial proteins
including Miro1 (MacAskill et al. 2009), with knockdown
of TRAK family members, particularly TRAK2, reducing
mitochondrial transport in neurons (Misko et al. 2010;
Brickley and Stephenson 2011; Lopez-Domenech et al.
2012; van Spronsen et al. 2013). It is notable that TRAK2
is also involved in the trafﬁcking of a number of transmem-
brane ion channels and receptors including Kir2.1, and
GABAA receptors in neurons, and it is possible that this
protein has a role in astrocytes.
In this study, we sought to deﬁne the extent of
co-localization of GLT-1 with mitochondria in primary
cultures of astrocytes. To test whether GLT-1 association
with mitochondria was regulated we used two conditions,
comparing pure astrocyte cultures with astrocytes co-cultured
with neurons. Co-cultures were also stimulated with 15 mM
potassium chloride for 1 h to drive neuronal excitability and
challenged with compounds that modulate Na+ gradients and
Na/K ATPase activity. In addition, we tested whether
dominant negative TRAK2 could disrupt potential GLT-1:
mitochondrial associations.
Materials and methods
Animal groups
Timed mated female NIH Swiss mice (Harlan, UK) were maintained
and used according to the UK Animals (Scientiﬁc Procedures) Act
(1986) and local ethical guidelines. Animals were killed using
cervical dislocation and cerebral cortices from E15 mouse embryos
were obtained and cells were mechanically disassociated by
triturating (20 times) with a sterile ﬁre polished 230 mm glass
Pasteur pipette (VWR International, East Grinstead, UK) pre-coated
with sterile foetal bovine serum [Foetal bovine serum (FBS),
Biosera, East Sussex, UK] in phosphate-buffered saline (PBS, Ca2+
and Mg2+ free) supplemented with glucose (33 mM), penicillin (100
units/mL) and streptomycin (0.1 mg/mL) as previously described
(Hoppe et al. 2013). The cell suspension was centrifuged (5 min,
200 g) and re-suspended in the appropriate media. For astrocyte
cultures, cells were plated in astrocyte speciﬁc media (DMEM/F-12
(HAM), Life Technologies, Grand Island, NY, USA) supplemented
with glucose (33 mM), L-glutamine (2 mM), FBS (10%) and
sodium bicarbonate (13 mM) at a density of 4 9 105 cells per well,
into 12 well plates containing 13 mm glass coverslips pre-coated
with poly-L-ornithine hydrobromide (1.5 lg/mL) for 24 h. After
10 days in vitro (DIV), primary cortical astrocytes were 80–90%
conﬂuent. Neurons were removed by banging the plates followed by
a wash with PBS and the addition of fresh media. Cultures were
transfected at day 11 and used at day 14.
Astrocyte-neuron co-cultures were plated in Eagle’s Minimum
Essential Medium with Earle’s balanced salt solution without L-
glutamine (MEM Eagle with Earles balanced salt solution, Lonza,
Slough, UK) supplemented with L-glutamine (0.5 mM), glucose
(15 mM), gentamicin sulphate (10 mg/mL) and 5% heat inacti-
vated horse serum (Sigma-Aldrich, St. Louis, MO, USA). Cells
were seeded at a density of 4 9 105 cells per well, into 12 well
plates containing 13 mm glass coverslips which had been pre-
coated with poly-D-lysine hydrobromide (0.1 mg/mL) for 10 min,
air dried, then coated with FBS. Astrocyte cultures showed 95%
purity and astrocyte – neuron co-cultures had 60% astrocytes to
40% neurons as assessed by immunostaining for glial ﬁbrillary
acidic protein (GFAP) (M076101-2, Dako UK Ltd., Ely, UK) and
microtubule-associated protein 2 (MAP-2) (SMI-52R, Covance
Inc., Leeds, UK), (data not shown). These cultures were transfected
at day 14 and used at day 17, the time was chosen to optimize the
electrophysiological activity of the neurons (results not shown).
Rho kinase inhibition and astrocyte toxicity
Primary mouse astrocytes (11 DIV) were treated with saline
(Vehicle – 0.1% total volume) and varying concentrations of
Y27632 (1, 10 and 100 lM) in 12 well plates and left for 24 h.
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After treatment, cells were washed with hank’s buffered media
(HBM) buffer (4.76 g HEPES, 40.88 g NaCl, 0.372 g KCl, 0.42 g
NaHCO3, 0.1654 g NaH2PO4, 0.3 g Glucose and 240 lL of 0.5 M
CaCl2 (Sigma, St. Louis, MO, USA)) and incubated with 500 lL of
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide) buffer [0.5 mg/mL Thiazoyl Blue Tetrazolium Bromide
(Sigma) in HBM] at 37°C for 1 h. The formazan precipitate was
then solubilized with 300 lL dimethylsulfoxide per well. 200 lL
from each well was transferred to a 96 well plate and absorbance
was measured using a plate reader (Flexstation 3, Molecular
Devices. k = 490 nm).
TRAK2 Expression in primary mouse astrocytes
RNA was extracted using the re-agent RNA Bee (AMS Biotech-
nology, Abingdon, UK). All RNA samples were derived from cells
growing in six well plates (8 9 105 cells per well). RNA bee was
added to each well (1 mL) and left on ice for 5 min. RNA was then
isolated using the chloroform based method of extraction, in
accordance with the manufacturer’s protocol. RNA concentrations
were calculated using a NanoDrop 2000 spectrophotometer (Thermo
Scientiﬁc, Waltham, MA, USA). A high capacity cDNA kit
(4368814 – Life Technologies) was used to transcribe 2 lg of
RNA. To perform PCR, the cDNA reaction mixture was diluted
1 : 20 in Tris-EDTA buffer (Sigma) and 3 lL of cDNA was
combined with 2 lL of both the forward and reverse primers
(2.5 lM stock, ﬁnal concentration 100 nM) and 43 lL of Megamix
pcr master mix (Microzone) to create a 50 lL reaction volume per
well. Each cDNA sample underwent 30 cycles of PCR before being
run on 1.5% agarose gels alongside the appropriate base pair ladder
(Hyperladder IV – Bioline, London, UK).
We used two sets of oligonucleotides to assay TRAK2 expression
designed against the sequence published by Beck et al. 2002 (NCBI
Accession Number NM_172406.3). The primer pairs were as
follows: TRAK2-A (F) 50-AATGTGGAGAGAGCGCAGTG-30
(bases 3298–3318) and (R) 50- CCAAGGCAAGGAAACGTAGC-
30 (bases 3455–3475 – fragment size 158 base pairs) and TRAK2-B
(F) 50-AAGCCGAGAAGCAGAAATGG-30 (bases 3012–3032) and
(R) 50- GGTGAGGTTGTGCAAACTGG -30 (bases 3158–3178 –
fragment size 147 base pairs). Primers were re-suspended in
nuclease free water, to a concentration of 2.5 lM.
Western blotting was carried out on astrocyte cultures and
mouse whole brain, using methods previously described (Bahia
et al. 2012). To probe for TRAK2 a rabbit antibody raised against
residues 8-633 that also recognizes TRAK1 was used (kind gift of
Professor F A Stephenson, UCL School of Pharmacy) and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH - monoclonal
goat anti-mouse, 1 : 10000; Life Technologies) was used as a
reference protein. Primary antibodies were incubated overnight at
4°C in tris buffered saline (TTBS) supplemented with Tween-20
(20 mM tris buffer (pH 7.5 – Sigma) containing 0.4% Tween-20
(Sigma) and 1% non-fat milk powder). The blots were washed in
TTBS and incubated with the corresponding goat anti-rabbit/goat
anti-mouse secondary antibodies conjugated to horseradish perox-
idase (1 : 5000; Sigma) at 23C for 1 h. After washing, mem-
branes were incubated with enhanced chemiluminescence reagent
(GE Healthcare, Little Chalfont, UK) for 2 min. The enhanced
chemiluminescence reagent was prepared according to the manu-
facturer’s protocol. Blots were imaged using the Chemidoc MP
imaging system (Biorad) for chemiluminescence and analysed by
the corresponding ImageLab software (Bio-Rad Laboratories,
Hercules, CA, USA). Images were exported from the software at
a resolution of 600dpi into photoshop CS3 and used for
representation.
Transfection and drug treatments
We used a V5 tagged GLT-1 plasmid, the MAST-KREK isoform
corresponding to the predominant splice variant, also known as
GLT-1a (Peacey et al. 2009), the commercially available pDs Red
1-mito plasmid (Clontech, Mountain View, CA, USA) for mito-
chondrial tracking and a green ﬂuorescent protein (GFP) tagged
dominant negative trafﬁcking adhesion kinase 2 (DN TRAK2)
plasmid (Brickley and Stephenson 2011). Primary mouse astrocytes
and co-cultures (10 and 18 DIV) were single, double or triple
transfected with plasmids using Lipofectamine 2000 (Life Technol-
ogies) according to manufacturer’s instructions, and as previously
described (Peacey et al. 2009). This transfection method results in
predominant astrocyte transfection. Whilst some neurons in co-
cultures were transfected; they were excluded from analysis based
on cell body size and morphology. Cells were left for 48 h before
washing and ﬁxing. After transfection, cells were washed with PBS
and fresh media was replaced. Transfected cells were then treated
with vehicle (0.1% sterile PBS) or the Rho Kinase inhibitor Y27632
(100 lM, Merck-Millipore, Watford, UK) for 24 or 48 h. In some
experiments, co-cultures were further treated with KCl (15 mM, pH
7.4) for 1 h following vehicle or Y27632 administration. In
additional experiments co-cultures were treated with ouabain
(1 lM), gramicidin (10.6 lM) or monensin (20 lM) for 4 h before
ﬁxing.
Immunofluorescence and cell imaging
Following treatments, cells were ﬁxed in 4% paraformaldehyde in
PBS (30 min). Unless otherwise stated, following ﬁxation, cells
were blocked and permeabilized in 1% normal goat serum and 0.2%
Triton-X100 (Sigma) in PBS, for 1 h at 23C. For visualization of
V5-GLT-1, cells were incubated overnight at 4°C with a mouse
monoclonal anti-V5 primary antibody (R960-25; Life Technologies)
diluted 1 in 1000 in PBS containing 1% Normal goat serum.
Coverslips were washed three times for 5 min in PBS then
incubated with a goat anti-mouse secondary antibody conjugated
to Alexaﬂuor 488 (Life technologies) for 90 min, at 23C.
Coverslips were then washed with PBS, with some incubated for
5 min with Hoescht 33342 in PBS (4 lg/mL; Life Technologies)
before mounting on slides using Vectashield mounting medium
(Vector Laboratories, Burlingame, CA, USA). Images were col-
lected on an (Zeiss Axioskop 2; Carl Zeiss Microscopy, LLC,
Thornwood, NY, USA) upright microscope using 40x and 100x
Plan-NeoFluar objectives, collected using a colour camera (Zeiss
AxioCam HRc colour camera, Carl Zeiss Microscopy) and
processed using Axiovision Software (Carl Zeiss Microscopy).
Zeiss Filter Sets 02/10 and 15 for DAPI/FITC/Rhodamine were used
to visualize staining. High-resolution images were created using
Photoshop CS3. Confocal z-stacks were generated using an inverted
Leica DMIRE2 microscope and processed using the accompanying
Leica confocal software (Manheim, Germany). A Leica HCX PL
APO 63x objective was used to generate 1024 9 1024 high-
resolution z-stacks. Representative z-stacks were opened in ImageJ
© 2014 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of
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(LOCI plugin – University of Wisconsin-Madison, Madison, WI,
USA) and deconvolved using the Tikhonov–Miller algorithm
(Deconvolution Lab plugin – Biomedical Image Group, EPFL,
Lausanne, Switzerland) for clarity before being exported to
Photoshop CS3. 3D isosurface and ﬂuorescence plots were derived
through Volocity software (6.1.1 Edition, Perkin Elmer, Cambridge,
UK). For the data shown in Table 1, a total of 20 z-stacks were
collected and analysed from three independent cultures, using data
from seven transfected cells from two cultures and six transfected
cells from the third and combined the results for statistical analysis,
with the exception of DN TRAK2 transfected pure astrocyte cultures
where 10 z-stacks were collected from three independent cultures
(3–4 cells from each culture).
Co-localization analysis
Co-localization was determined using confocal microscopy and
Volocity image analysis software. Firstly, a library of ﬁles was
generated by importing all the TIFF images into the software. Using
the green and red 8-bit images (V5 and pDs Red-1 Mito
respectively), image sequences were generated allowing co-locali-
zation in the whole image to be determined using automatic
thresholding, to generate the best threshold for each image sequence
(Costes et al. 2004). The software allowed Costes Pearson’s
correlation coefﬁcient (1 to +1) and correlation coefﬁcient M1
and M2 (representing co-localized voxels in each channel) to be
determined. We analysed 20 images per parameter (minimum of 50
frames per channel) and then averaged the Costes Pearson’s
correlation coefﬁcient to determine the degree of co-localization
for each experimental condition.
Statistical analysis
Statistical comparison of treatment groups was carried out using
ANOVA followed by Dunnett’s post hoc test (Prism, GraphPad
Software Inc., La Jolla, CA, USA).
Results
Mitochondrial and GLT-1 co-localization in astrocytes
The V5 tagged GLT-1 (V5-GLT-1) plasmid results in
predominant expression of GLT-1 at the plasma membrane,
with negligible expression in intracellular compartments, as
previously shown (Peacey et al. 2009) (Fig. 1a and b).
Transfection with pDs Red-1 mito, a mitochondrial tracking
plasmid shows discrete punctate distribution throughout the
cytosol of astrocytes, with little localization of mitochondria
Table 1 Quantiﬁcation of mitochondrial: GLT-1 co-localization in cultures analysed by confocal microscopy
Astrocytes alone
Astrocytes cultured with
neurons
Astrocytes alone +
DNTRAK2
Astrocytes cultured with neurons +
DNTRAK2
No drug
treatment
0.04  0.04 (20) 0.19  0.03 (20)** 0.06  0.06 (10) 0.18  0.02 (20)*
Y27632 0.05  0.04 (20) 0.05  0.04 (20) 0.09  0.03 (20) 0.05  0.03 (20)
Primary cultures were co-transfected with V5-GLT-1 and pDs-Red1 mito (with or without dominant negative TRAK2) then treated with vehicle or
Y27632 (100 lM, 24 h) and analysed for GLT-1: mitochondrial co-localization. Values represent Costes Pearson’s correlation coefﬁcient (1 to +1;
strong negative to strong positive correlation) with SEM and number of cells analysed for each condition. n = 3 independent cultures. Data
analysed by Two-Way ANOVA. ND = not determined. Asterisks represent signiﬁcance when compared with astrocytes alone (**) and astrocytes plus
DN TRAK2(*).
(a) (c) (e)
(b) (d) (f)
Fig. 1 Expression of transfected proteins in primary mouse astrocytes.
(a, b) Immunohistochemistry showing V5 expression (green) to localize
Glutamate Transporter 1 (GLT-1). (c, d) pDs Red-1 mito expression to
localize astrocyte mitochondria. (e, f) Green ﬂuorescent protein (GFP)
expression following Dominant negative (DN) TRAK2 transfection.
(b, d, f) represent higher magniﬁcations of the parts of images boxed in
(a, c, e). Scale bar (a, c, e) = 10 lm (b, d, f) = 2 lm.
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in ﬁlopodia (Fig. 1c and d). The construct expressing the
dominant negative trafﬁcking kinesin 2 (DN TRAK2,
previously characterized and described by Brickley and
Stephenson (2011)) also expresses GFP through an internal
ribosome entry site motif. GFP was evenly distributed
throughout the cytoplasm of transfected astrocytes (Fig. 1e
and f).
To explore potential links between mitochondria and
GLT-1, ﬁrstly astrocytes were double transfected with pDs
red-1 mito and V5-GLT-1 plasmids (Fig. 2) and analysed
by confocal microscopy. The overlap between green (GLT-
1) and red (mitochondria) ﬂuorescence was assessed by eye
and using Volocity software. Very few areas of co-
localization were visible by eye, an observation further
reinforced by a Costes Pearson’s coefﬁcient of 0.04  0.04
(Table 1) indicating no correlation between V5-GLT-1 and
mitochondria in primary cultures of pure astrocytes. Using
unpermeablized cultures, to visualize cell-surface GLT-1
exclusively gave the same result. We also found a negative
correlation between both proteins (0.06  0.04) when
V5-GLT-1 and pDs Red-1 mito are co-expressed in COS-7
cells.
Y27632 toxicity in primary cultures
To show that astrocyte stellation was not because of toxicity,
astrocytes were treated with varying doses of the inhibitor
Y27632 (1, 10 and 100 lM). At 24 h, each concentration
showed no signiﬁcant difference in MTT turnover compar-
ative to saline treated controls, as determined by one-way
ANOVA followed by Dunnett’s post hoc to compare all
columns (F = 0.97, p = 0.4531), data not shown. Phase
contrast time lapse videos taken over 24 h (Data S1) also
support this ﬁnding. In co-cultures, we stained for MAP2 and
GFAP after 4 h and 24 h Y27632 treatment. Co-cultures
showed no visible difference in neuronal number or
morphology upon rho kinase inhibition at both time points
(data not shown).
Effect of Rho kinase inhibition and co-culture with neurons
on GLT-1: mitochondrial co-localization
As Rho kinase inhibition increases astrocyte stellation and
increases GLT-1 expression at the cell surface (Lau et al.
2011), we hypothesized it would increase co-localization of
mitochondria with GLT-1. Therefore, we treated double
transfected cells with the Rho Kinase inhibitor Y27632
(100 lM) for 24 h then monitored mitochondrial and V5-
GLT-1 co-localization (Fig. 3). Co-cultures were treated for
4 h with the inhibitor. Rho Kinase inhibition caused
marked astrocyte stellation and formation of many ﬁne
ﬁlopodia, decorated with V5-GLT1 (Data S2) but did not
markedly alter the distribution of mitochondria within the
astrocytes. Fewer GLT-1 co-localized mitochondria were
visible by eye and as for control cultures, in Y27632
treated cultures, mitochondria and GLT-1 showed no
positive correlation (Costes Pearson’s coefﬁcient of
0.05  0.04, Table 1).
Neurons drive co-localization of GLT-1 and mitochondria
Next, astrocyte-neuron co-cultures were generated as astro-
cytes in the presence of neurons would be expected to have
mitochondria and GLT-1 more densely packed into astrocyte
processes and possibly ﬁlopodia, enhancing co-localization.
Cultures were transfected with plasmids encoding V5-GLT-1
and DsRed-1-mito and analysed with and without treatment
with Y27632. Under these conditions, there was increased
recruitment of mitochondria into ﬁlopodia (Fig. 4a), which
(a) (b) (c)
(d) (e) (f)
Fig. 2 Limited co-localization of mitochondria with GLT-1 in primary
astrocytes. Fluorescence microscopy of primary mouse astrocytes
transfected with plasmids encoding V5-GLT-1 and DsRed-1 mito. (a,
b) show staining with anti-V5 (green), (c, d) show mitochondria (red)
and (e, f) show a composite image allowing visual analysis of co-
localization. Nuclei are counterstained with Hoescht 33342 (blue). (b,
d, f) represent higher magniﬁcations of the parts of images boxed in (a,
c, e). Scale bar (a, c, e) = 10 lm, (b, d, f) = 1 lm.
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was particularly pronounced following Rho kinase inhibition
(Fig. 4b). While, in co-cultures, there was modest overlap of
mitochondria and GLT-1 observed by eye, quantiﬁcation
revealed signiﬁcant positive correlation with a Costes
Pearson’s coefﬁcient of 0.19  0.03, (Table 1). Two-Way
ANOVA revealed a signiﬁcant increase in co-localization
between GLT-1 and mitochondria in co-culture conditions
when compared with pure astrocyte controls (F(1,20) = 11.8,
p < 0.001). Representative three-dimensional ﬂuorescence
and isosurface plots are shown in Figure 5.
(a) (b) (c)
(d) (e) (f)
Fig. 3 Rho kinase inhibition causes astrocyte stellation without
enhancing co-localization of mitochondria and GLT-1 in pure astrocyte
cultures. Astrocytes co-transfected to express V5-GLT-1 (green) and
DsRed-1 mito (red), were treated with Y27632 (100 lM, 24 h). (a, b)
show staining with anti-V5 (green), (c, d) show mitochondria (red) and
(e, f) show a composite image allowing visual analysis of co-
localization. Nuclei are counterstained with Hoescht 33342 (blue). (b,
d, f) represent higher magniﬁcations of the parts of images boxed in (a,
c, e). Scale bar (a, c, e) = 10 lm, (b, d, f) = 1 lm.
(a) (i) (ii) (iii)
(i) (ii) (iii)(b)
Fig. 4 Glutamate Transporter 1 (GLT-1): mitochondria co-localization
in astrocytes co-cultured with neurons. Astrocyte, neuron co-cultures
were co-transfected with plasmids encoding V5-GLT-1 (green) and
DsRed-1 mito (red). (a) Representative untreated control cell and (b)
representative cell treated with Y27632, each with higher magniﬁcation
insets showing (i) V5-GLT-1, (ii) mitochondria (iii) overlay of both
revealing increased mitochondrial localization in ﬁlopodia, but with
limited GLT-1: mitochondrial co-localization in Y27632 treated astro-
cytes. White arrowheads indicate the appearance of mitochondria in
astrocyte ﬁlopodia when cultured with neurons (a(iii)) and when co-
cultured astrocytes change to a stellate morphology (b(iii)). Scale bar
(a, b) = 10 lm, (i)–(iii) = 5 lm.
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In astrocytes co-cultured with neurons and treated with
Y27632, while there appeared to be increased distribution of
mitochondria in astrocyte processes (Fig. 4b) this treatment
signiﬁcantly decreased mitochondrial and V5-GLT-1
co-localization as the Costes Pearson’s coefﬁcient was
0.05  0.04 (Table 1). The decrease in co-localized
GLT-1 and mitochondria caused in astrocytes co-cultured
with neurons stimulated with Y27632 was highly signiﬁcant
(F(1,20) = 10.45 p < 0.01).
Effect of neuronal stimulation and sodium ion gradient
manipulation on GLT-1/mitochondrial co-localization
Whilst we showed that there is indeed a positive correlation
between GLT-1 and mitochondria when neurons are cultured
with astrocytes, we hypothesized that stimulating neuronal
depolarization would encourage further re-distribution of
mitochondria and GLT-1 to astrocyte processes, enhancing
co-localization. We stimulated co-cultures (18 DIV) with
15 mM KCl for 1 h and analysed co-localization. Interest-
ingly, we found no further increase in co-localization in co-
culture controls treated with KCl (0.16  0.05), suggesting
that the degree of co-localization could not be further
stimulated.
We also carried out a series of experiments to test the
effect of manipulating the sodium ion gradient in co-cultures.
Astrocytes have numerous mechanisms which regulate
sodium ions and glutamate transport is dependent on the
sodium gradient (Rose and Karus 2013). We used ouabain
(1 lM), a Na/K-ATPase inhibitor also reported to increase
co-localization of Na/K-ATPase to GLT-1 (Rose et al.
2009), gramicidin (10.6 lM), a sodium ionophore also
reported to inhibit Na/K-ATPase (Takada et al. 2008) and
monensin (20 lM), an alternative sodium ionophore, that is
also reported to stimulate Na/K-ATPase in astrocytes (She-
ean et al. 2013). None of these agents had a signiﬁcant effect
on the extent of co-localization of mitochondria with GLT-1
(results not shown).
Effect of TRAK2 inactivation on astrocyte morphology,
mitochondrial distribution and GLT-1: mitochondria
co-localization
Using PCR we found that under normal conditions, astro-
cytes express TRAK2 mRNA (Fig. 6a). Interestingly, using
Western Blotting, TRAK2 protein was not detectable in
astrocytes cultured alone, but prominent in astrocytes
co-cultured with neurons (Fig. 6b). We tested the effect of
co-expression of a dominant negative form of TRAK2 (DN
TRAK2) on co-localization of GLT-1 and mitochondria in
primary astrocytes. We measured co-localization in the
presence and absence of the rho kinase inhibitor, Y27632 in
pure cultures (not shown) and astrocytes co-cultured with
neurons (Fig. 6). We note that expression of DN TRAK2 had
no obvious effect on astrocyte morphology, nor did it
markedly alter the distribution of mitochondria within
(a)
(b)
(d)
(c)
(f)
(e)
Fig. 5 Co-localization in co-cultures using
confocal microscopy. Astrocytes in pure cultures
(a–c) have fewer co-localized voxels in comparison
to co-cultures (d–f) as determined by Volocity
software. (a+d) Fluorescence 3D plots showing co-
localization of green and red pixels in the z-stacks.
(b+e) 3D iso-surface reconstruction showing co-
localized points in each z-stack. Green channels
represent V5-GLT-1 ﬂuorescence, whereas pDs
Red-1 mito expression can be seen in the red
channel. c+f) Co-localization observed in
deconvolved z-stacks (Tikhonov-Miller algorithm).
After deconvolution, a snapshot was taken from
the z-stack and processed using photoshop CS3.
White arrowheads indicate co-localized voxels in
astrocytes cultured with neurons. Mitochondria can
be found throughout the cell body and processes.
Scale bar = 10 lm.
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astrocytes, either in pure cultures or when cultured with
astrocytes. As for the previous experiments, very little
co-localization was observable by eye. Measurement of
co-localization using Volocity software (Table 1) revealed
that co-localization of GLT-1 and mitochondria was similar
to values found in cultures without DN TRAK2 expression.
Two-Way ANOVA revealed no signiﬁcant effect on co-
localization between GLT-1 and mitochondria caused by
either Y27632 treatment (F(1,20) = 2.29, p = 0.135) or
co-culturing with neurons (F(1,20) = 2.07, p = 0.155).
Discussion
Recent evidence has pointed to the existence of a physical
link between mitochondria and GLT-1 in astrocytes (Genda
et al. 2011). While this link has been convincingly demon-
strated biochemically, there is so far only a single detailed
examination of the overlap using imaging techniques (Jack-
son et al. 2014). To examine this interaction in more depth
we used a model system of primary mouse astrocytes and
astrocyte neuron co-cultures to monitor levels of co-locali-
zation between epitope tagged GLT-1 (Peacey et al. 2009)
and a mitochondrial tracking marker (DS Red 1 mito).
We used confocal microscopy to investigate the associa-
tion between GLT-1 and mitochondria using Volocity
software to calculate the level of co-localization between
these two proteins. We found no association between GLT-1
and mitochondria in pure primary astrocytes, whereas in
primary astrocytes cultured with neurons, there was an
increased distribution of mitochondria into the thicker
processes, as well as a small meaningful positive correlation
between GLT-1 and mitochondria, that is a greater degree of
overlap than expected by chance. Volocity software provides
a sophisticated and useful method of analysing co-localiza-
tion through the generation of three-dimensional ﬂuores-
cence/isosurface maps to identify true regions of
co-localization. The 3D data show more co-localized voxels
in control cells from the co-cultures in comparison to control
cells in astrocyte cultures. Altogether our results suggest that
in co-cultures, that is cultures containing functional neurons;
mitochondria invade ﬁlopodia and become closer to the
plasma membrane, with some co-localizing with GLT-1. The
signiﬁcant increase in correlation between mitochondria and
GLT-1 localization in co-cultures compared to pure astrocyte
cultures is consistent with the notion that neuronal activity
drives GLT-1 mitochondrial co-localization. This observa-
tion supports the data of the Robinson group, who surveyed
GLT-1:mito co-localization in astrocytes in brain slices,
although they observed a greater degree of co-localization
than we ﬁnd in primary astrocyte cultures (Genda et al.
(a)
(c)
(b)
Fig. 6 Dominant negative TRAK2 does not alter mitochondrial: Gluta-
mate Transporter 1 (GLT-1) co-localization in astrocytes. (a)TRAK2
mRNA is present in pure astrocyte cultures (AST) and whole brain
(WB), as identiﬁed using two distinct pairs of oligonucleotides TRAK2-A
(158 bp fragment) and TRAK2-B (147 bp fragment). GAPDH was used
as a housekeeping gene; to show equal concentrations of cDNA were
loaded. (b) TRAK2 (102 kDa) protein is expressed in co-cultures (Co)
but undetectable in pure cultures of cortical astrocytes (Ast), neurons
(CN) and whole brain (WB). GAPDH was used as a reference protein
for protein loading. (c) Immunoﬂuorescence microscopy showing
GLT-1 (green) and mitochondria (red) in astrocyte-neuron co-cultures
transfected with plasmids encoding DsRed-1 mito and V5-GLT-1 (1-4),
with DNTRAK2 (5-8). Cells were treated with vehicle (1,2,5,6) or the rho
kinase inhibitor Y27632 (3,4,7,8). Scale bar (a–h) = 5 lm.
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2011; Jackson et al. 2014). We note that whilst co-localiza-
tion is present in our experiments, the proportion of
mitochondria co-localizing with GLT-1, and vice versa, is
very small, we estimate < 1%, even under conditions of co-
culture. Therefore, the physiological signiﬁcance of this
small degree of co-localization is still questionable, partic-
ularly as there is little evidence of mitochondria being present
in the ﬁne astrocyte ﬁlopodia which are rich in glutamate
transporters (Hertz et al. 2007). We note that the diameter of
the smallest processes (peripheral astrocyte processes) are
reported to be < 50 nm, too small to house mitochondria
(Lavialle et al. 2011).
Stimulation of co-cultures with 15 mM K+ does not further
enhance co-localization between these two proteins
(0.16  0.05), suggesting that co-culture alone permits the
maximum level of co-localization. We also show that the
extent of co-localization is not affected by manipulation of
the sodium ion gradient or modulation of Na/K ATPase.
Further studies will provide insight into whether there are
conditions which further promote such co-localization.
We note that the method used to culture astrocytes here
supports high levels of L-glutamate uptake (Tortarolo et al.
2004; Peacey et al. 2009). We have chosen to use transfec-
tion of a tagged GLT-1 construct to enable visualization of
the transporter in ﬁne processes, which provides a signiﬁcant
technical advantage above visualization of endogenous GLT-
1. The localization and properties of our tagged GLT-1 in
astrocytes is indistinguishable from native GLT-1, deter-
mined by a range of biochemical methods (Peacey et al.
2009), however, we cannot rule out that the tagged GLT-1
used here may differ in its coupling to mitochondria to
endogenous GLT-1, accounting for a degree of difference in
the proportion of co-localization reported here compared to
the two other published reports (Genda et al. 2011; Jackson
et al. 2014).
In pure astrocyte cultures, mitochondrial localization in
astrocyte processes was rare. While we did not quantify
mitochondrial distribution and movement in this study, we
note that two of the treatments used: co-culture with neurons
and treatment with the rho kinase inhibitor, Y27632, resulted
in mitochondria being readily detectable in the thicker
astrocyte processes. These observations support recent data
showing that mitochondria in astrocytes are highly motile,
with their re-localization mediated by intracellular calcium
(Kremneva et al. 2013). The movement of mitochondria to
astrocyte processes brings them closer to the plasma
membrane, so even if there is not direct co-localization there
is less distance for diffusion of ATP required for the sodium-
potassium ATPase to drive GLT-1 activity. Our current data
suggest that neuronal inﬂuences alone are sufﬁcient to cause
re-localization of mitochondria, and that it is not the sodium
ion gradient or Na/K ATPase activity which is the main
driver. Further work remains to detail the mechanisms
regulating glutamate transporter: mitochondrial interaction.
This study is the ﬁrst report of expression of TRAK2
mRNA in astrocytes and inhibition of TRAK2 in astrocytes.
The currently available reagents precluded a detailed study of
TRAK2 localization at the cellular level. Our results suggest
an intriguing regulation of TRAK2, with protein expression
in astrocyte cultures dependent on the presence of neurons.
The functions of TRAK2 in astrocytes are not yet known. In
this study, we note that treatment with dominant negative
TRAK2 did not markedly affect cell shape, GLT-1 distribu-
tion or mitochondrial distribution in either pure astrocyte
cultures or astrocyte neuron co-cultures. This preliminary
evidence suggests that TRAK2 is not a mediator of GLT-1:
mitochondrial interactions in astrocytes.
In closing, here we show that there is no co-localization of
GLT-1 and mitochondria in our astrocyte cultures, however,
in astrocyte-neuron co-cultures; we begin to see a small
positive correlation. This correlation may increase depending
on the age of the cell population, which if true, may represent
a more biologically signiﬁcant coupling.
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